DENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Current ratio
DENTSPLY SIRONA Inc.'s current ratio at the end of the quarter to 30 September 2026 was 1.6×, up 0.1× from fiscal 2025 (1.5×). Over the past ten years it has ranged from 1.1× (fiscal 2024) to 2.5× (fiscal 2015); the current reading is higher than 45% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.5× | 37.09% |
| FY2024 | 1.1× | (20.64%) |
| FY2023 | 1.4× | (14.42%) |
| FY2022 | 1.6× | 10.16% |
| FY2021 | 1.5× | 12.07% |
| FY2020 | 1.3× | (34.80%) |
| FY2019 | 2.0× | 7.88% |
| FY2018 | 1.9× | (11.19%) |
| FY2017 | 2.1× | (7.63%) |
| FY2016 | 2.3× | (9.65%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.6× | (0.10%) |
| Jun 2026 | 1.6× | 6.44% |
| Mar 2026 | 1.5× | 1.48% |
| Dec 2025 | 1.5× | 2.14% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| LMAT LeMaitre Vascular, Inc. compare | 14.6× |
| PLSE Pulse Biosciences, Inc compare | 14.3× |
| KMTS Kestra Medical Technologies, Ltd. compare | 4.7× |
| STAA STAAR Surgical Company compare | 4.7× |
| ATRC AtriCure, Inc. compare | 4.3× |
| AZTA Azenta, Inc. compare | 2.5× |
| WRBY Warby Parker Inc. compare | 2.3× |
| STVN Stevanato Group S.p.A. compare | 1.7× |
| XRAY DENTSPLY SIRONA Inc. | 1.6× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement